Shay Capital’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-27,000
Closed -$31.1K 246
2024
Q3
$31.1K Buy
+27,000
New +$31.1K ﹤0.01% 229